Research programme: androgen receptor antagonists - Pfizer
Alternative Names: PF-0998425; PF-998425Latest Information Update: 16 Jul 2016
At a glance
- Originator Pfizer
- Class Benzonitrile; Cyclohexanols; Small molecules
- Mechanism of Action Androgen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Skin disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Skin-disorders in USA
- 15 Oct 2008 Preclinical trials in Skin disorders in USA (unspecified route)